Cell Signaling Technology

Product Pathways - Translational Control

Exportin 5 Antibody #12068

Applications Reactivity Sensitivity MW (kDa) Source
W H (Hm) (Mk) (B) (Pg) (Hr) Endogenous 136 Rabbit

Applications Key:  W=Western Blotting
Reactivity Key:  H=Human  Hm=Hamster  Mk=Monkey  B=Bovine  Pg=Pig  Hr=Horse
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

Protocols

Specificity / Sensitivity

Exportin 5 Antibody recognizes endogenous levels of total exportin 5 protein.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu182 of human exportin 5 protein. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from various cell lines using Exportin 5 Antibody.

Background

Import and export through the nuclear envelope (NE) via facilitated translocation is important for many cellular processes including protein synthesis and miRNA biogenesis (1). Exportin 5 (XPO5) is a member of the importin β family of proteins (2) and functions in tRNA export in a sequence dependent fashion. More recently, it has been shown to export pre-miRNA by a RanGTPase-driven process from the nucleus to the cytoplasm, where pre-miRNA processing occurs to produce mature miRNAs (1,3). Study of the miRNA biosynthesis pathway is essential toward understanding the process of oncogenesis as global downregulation of miRNAs and the resulting alterations in expression of tumor suppressor and oncogenic proteins is a common phenotype of cancers cells (3,4). Research studies have shown that disruption of exportin 5 functions in many types of cancers including breast and lung, where pre-miRNA accumulates in the nucleus and miRNA maturation is impaired (2,3).

  1. Bohnsack, M.T. et al. (2004) RNA 10, 185-91.
  2. Leaderer, D. et al. (2011) Int J Mol Epidemiol Genet 2, 9-18.
  3. Melo, S.A. and Esteller, M. (2011) Cell Cycle 10, 922-5.
  4. Melo, S.A. et al. (2010) Cancer Cell 18, 303-15.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products


For Research Use Only. Not For Use In Diagnostic Procedures.

Products